Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06096805

Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR)

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Shanghai First Maternity and Infant Hospital · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers

Summary

This study intends to prospectively enroll high-risk pregnant women to establish a multicenter cohort. By combining maternal basic characteristics, medical history, early pregnancy ultrasound, and biological markers, we aim to construct a joint predictive model for MVM-FGR.

Detailed description

Clinical guidelines do not recommend clinical screening for MVM-FGR in low-risk populations. Predictive models for FGR are often based on preeclampsia prediction models or Down syndrome serum screening models, which have limited utility. This study aims to establish a multi-center prospective cohort of pregnant women at high risk for FGR. We will collect baseline characteristics of pregnant women, ultrasound measurements of fetal growth, structural scans, maternal-fetal Doppler blood flow, as well as maternal serum and plasma in first and mid-trimester. Serum and plasma biomarker testing will be conducted. We will regularly observe fetal growth data, maternal-fetal complications during pregnancy, and collect delivery information, conditions of the newborn and placental pathology results after birth. By integrating maternal medical history, serum and plasma biomarkers, Doppler ultrasound, and other factors, we will establish a combined predictive model for early and mid-term MVM-FGR.

Conditions

Timeline

Start date
2023-08-10
Primary completion
2025-12-30
Completion
2025-12-30
First posted
2023-10-24
Last updated
2024-06-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06096805. Inclusion in this directory is not an endorsement.